Contribution of Inhibitor of DNA Binding/Differentiation-3 and Endocrine Disrupting Chemicals to Pathophysiological Aspects of Chronic Disease

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/bmri/volume-2017/6307109/figures/6307109.fig.005a.svgz" name="6307109.fig.005a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Summary of ID3 signaling pathways involved in colon and lung cancer (left panel). ID3 contribution to tumor angiogenesis in brain cancer (right panel)</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/bmri/volume-2017/6307109/figures/6307109.fig.005b.svgz" name="6307109.fig.005b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>ID3 signaling pathways involved in brain cancer are summarized in the illustration</td></tr></table>

BioMed Research International

fig5

Figure 5

Figure 5: Contribution of Inhibitor of DNA Binding/Differentiation-3 and Endocrine Disrupting Chemicals to Pathophysiological Aspects of Chronic Disease 

Figure 5 | Contribution of Inhibitor of DNA Binding/Differentiation-3 and Endocrine Disrupting Chemicals to Pathophysiological Aspects of Chronic Disease 